INTRODUCTION
============

Epithelial cells normally form an immobile barrier that line organs and luminal space. However, they can become highly migratory during certain conditions, such as wound healing ([@B15]; [@B47]; [@B62]), developmental morphogenesis ([@B4]; [@B59]), and cancer metastasis ([@B52]; [@B74]). Epithelial cell migration is mediated in part by molecular switches called small GTPases ([@B43]). Small GTPases bind guanine nucleotide and cycle between an active, GTP-bound state and an inactive, GDP-bound state. Accessory proteins called GTPase-activating proteins (GAPs) stimulate the GTPase to hydrolyze the bound GTP, and guanine nucleotide exchange factors (GEFs) displace bound GDP, allowing GTP to bind and activate the GTPase. In the GTP-bound state, small GTPases can associate with effector proteins to activate downstream pathways.

ADP-ribosylation factor (ARF) small GTPases are regulators of intracellular vesicular traffic. They mediate traffic by recruiting coat proteins and directly activating enzymes that modify membrane lipids ([@B14]; [@B61]). There are three classes of ARFs: class I ARFs (ARF1, ARF2, ARF3) and class II ARFs (ARF4, ARF5) regulate traffic near the Golgi. ARF6, the only member of the class III ARFs, regulates traffic near the plasma membrane. ARF6 is different from other ARF GTPases, in that its expression leads to reorganization of cortical actin ([@B49]; [@B69]; [@B47]; [@B68]). Of importance, ARF1 also functions near the periphery during dynamic plasma membrane events ([@B2]; [@B9]).

Although several ARF-GEFs help regulate endocytosis and recycling, the cytohesin family of ARF GEFs is of particular interest because they are involved in altering cell shape, migration, and recycling of integrins ([@B16]; [@B47]; [@B48]; [@B7]; [@B38], [@B39]; [@B79]; [@B53]; [@B60]). There are four members of the cytohesin family of ARF-GEFs. They all contain a N-terminal coiled-coil domain, a conserved catalytic Sec7 domain, a pleckstrin homology (PH) domain, and a short C-terminal polybasic domain ([@B7]). The Sec7 domain contains a highly conserved and invariant glutamic acid that displaces bound GDP through repelling charges ([@B3]; [@B66]).

Cytohesin-2/ADP-ribosylation factor nucleotide site opener (ARNO) is a robust activator of ARF6 when overexpressed and causes cells to migrate in culture through downstream activation of Rac1 ([@B47]; [@B48]). Cytohesin-2/ARNO is also required for β1-integrin recycling ([@B38], [@B39]). Disrupting integrin recycling has negative effects on cell migration ([@B41]; [@B78]; [@B38], [@B39]). The N-terminal coiled-coil domain of cytohesin-2/ARNO serves two functions: it acts as an autoinhibitor of cytohesin-2/ARNO function ([@B23]) and as a scaffold by promoting the assembly a multiprotein complex containing scaffolding proteins GRASP and CNK3/IPCEF1 and the Rac-GEF DOCK180/Elmo ([@B53]; [@B58]; [@B1]). Therefore, by activating ARF6 and forming a complex with DOCK180/Elmo, cytohesin-2/ARNO promotes downstream activation of Rac1 and cell migration.

R-Ras is more distantly related to better-known members of the Ras family (H-, K-, N-Ras; [@B34]). R-Ras promotes cell spreading, adhesion formation, plasma membrane ruffling, and integrin activation ([@B17]; [@B31]; [@B24]; [@B64]; [@B55]; [@B10]; [@B46]). R-Ras is mainly expressed in vascular tissue ([@B30]) but has been shown to be critical for adhesion and migration in fibroblasts and epithelial cells in culture. Although specific mutations in R-Ras have not been associated with cancer, R-Ras has been found to be up-regulated in cervical cancer ([@B18]), gastric cancers ([@B36]), prostate cancer ([@B54]), and gliomas ([@B35]). The importance of R-Ras in migration has been demonstrated across multiple cell types, including skeletal myoblast ([@B50]), myeloid ([@B24]), endothelial ([@B46]), fibroblast ([@B20]), and epithelial ([@B28]; [@B17]; [@B72]; [@B64]; [@B65]).

Recent evidence suggests that cytohesin-2/ARNO and small the GTPase R-Ras function in the same signaling pathway to promote cell migration ([@B20]; [@B33]; [@B67]). Overexpression of constitutively active (38V) R-Ras causes a scattering phenotype in Madin--Darby canine kidney (MDCK) cells that is very similar to that in cells expressing cytohesin-2/ARNO ([@B29]; [@B47]). R-Ras also has been shown to feed into the activation of Rac1 ([@B20]; [@B46]; [@B33]). A unique R-Ras effector, Ral-interacting protein of 76 kDa (RLIP76), associates with cytohesin-2/ARNO ([@B20]), and this interaction is required for ARF6 activation and migration ([@B33]). However, a precise mechanism of how R-Ras enhances cell spreading through integrin regulation is not clear. Rather than directly promoting integrin activation, as was once suggested ([@B57]), much of the early data show an indirect mechanism by which R-Ras inhibits integrin suppression mediated by H-Ras ([@B25]; [@B70]; [@B75]; [@B63]). Others have shown that R-Ras does not directly change the binding affinity of integrins ([@B31]) and does not increase the total amount of cell surface integrin ([@B57]; [@B72]; [@B46]). One way in which R-Ras could promote integrin activation is by regulating the recycling of integrins from internal compartments to the periphery ([@B51]). β1-Integrin recycles using many Rab small GTPases, including Rab21 ([@B40]), Rab11 ([@B41]), Rab8 ([@B22]), Rab4 ([@B44]), and Rab25 ([@B8]), as well as ARF6 ([@B41]) and Eps-15 homology domain--containing protein 1 (EHD1; [@B27]).

It is clear that as a regulator of integrin function, R-Ras could recycle within a similar compartment as integrins. A distinct population of R-Ras that localizes at the peripheral plasma membrane promotes the clustering and eventual endocytosis of β1-integrin in COS-7 cells ([@B10]). In endothelial cells, R-Ras, Rab5, and Rab5-adaptor RIN2 escort integrins bound to extracellular matrix to early endosomes ([@B46]). R-Ras has been shown to traffic using Rab11 ([@B10]; [@B56]), and posttranslational lipid modifications are critical for proper sorting and recycling of R-Ras ([@B56]). Furthermore, endogenous R-Ras has been described to be in tubular-like compartments in NIH-3T3 fibroblasts ([@B56]).

Given evidence that that R-Ras, cytohesin-2/ARNO, and ARF6 function in a similar pathway to promote migration and integrin recycling, we wondered whether cytohesin-2/ARNO could direct trafficking of R-Ras and integrin from an internal compartment to the plasma membrane.

RESULTS
=======

The GEF-activity of cytohesin-2/ARNO affects the morphology of EHD1-positive recycling endosomes
------------------------------------------------------------------------------------------------

At the start of endocytosis, peripheral ARFs (i.e., ARF6 and ARF1) are activated at the plasma membrane and are subsequently inactivated before merging with endosomes ([@B12]; Grant and Donaldson, 2009). When cargo is ready to exit recycling endosomes and traffic back out to the plasma membrane, ARFs are again activated, allowing vesicles to bud off and recycle back out to the plasma membrane. EHD1 associates with preexisting tubular membrane of the endocytic recycling compartment (ERC). EHD1-positive recycling endosomes are also enriched with ARF6 ([@B6]). The ERC is particularly easy to visualize in HeLa cells expressing EHD1, as they form distinct tubular structures. When we plated HeLa cells on fibronectin matrix and allowed them to express Cerulean-EHD1, cells formed mostly small, punctate EHD1 endosomes and individual tubes that extend radially from the perinucleus ([Figure 1A](#F1){ref-type="fig"}). In contrast, cells expressing wild-type (WT) cytohesin-2/ARNO showed almost exclusively punctate EHD1 endosomes with very limited elongated tubular structure. A population of EHD1 was seen at the periphery of cells at sites enriched with mCherry WT-ARNO ([Figure 1B](#F1){ref-type="fig"}). In contrast to both EHD1 and EHD1/WT-ARNO--transfected cells, HeLa cells expressing GEF-inactive (E156K) cytohesin-2/ARNO were noticeably less spread and showed more intracellular EHD1 in the form dense, perinuclear accumulation or as extensive tubular formations that could extend through the entire length of the cell ([Figure 1C](#F1){ref-type="fig"}). These data suggest that if cytohesin-2/ARNO--induced ARF activation is blocked, EHD1-positive vesicles will no longer be able to properly recycle, causing an accumulation of cargo in the ERC.

![Cytohesin-2/ARNO colocalizes with EHD1-positive endosomes and affects their morphology. (A--C) HeLa cells were transfected using Neon electroporation and allowed to express overnight. The next day, cells were treated with 0% saponin permeabilization buffer and fixed and imaged. Black arrows show EHD1 tubules. (D--G) HeLa cells were transfected as described for A--C. Before fixation, cells were permeabilized with 0.02% saponin for 1 min, washed quickly with PBS, and then fixed. In the merged image, EHD1 is pseudocolored cyan and ARNO is red. (H) Cells treated in A--C were masked for whole-cell area using SlideBook 6.0 software. A 2D Laplacian filter was applied to the EHD1 channel and subsequently masked. The endosomal area was measured, and the ratio of endosomal area per whole-cell area was graphed. Images underwent deconvolution using SlideBook 6.0 (EHD1, 47 cells; EHD1/WT-ARNO, 32 cells; EHD1/E156K, 76 cells). Samples were analyzed from two independent experiments using a two-sample *t* test using MiniTab 17. \*\*\**p* \< 0.001, \*\**p* \< 0.01, \**p* \< 0.05. Scale bars, 20 μm.](4265fig1){#F1}

If cytohesin-2/ARNO regulates recycling from EHD1 endosomes and activates ARFs there, we should be able to visualize membrane-bound cytohesin-2/ARNO on EHD1-positive endosomes. Cytohesin-2/ARNO is mostly cytosolic, and initial coexpression of Cerulean-EHD1 and mCherry-ARNO did not clearly resolve colocalization on EHD1 endosomes. Overall EHD1 and cytohesin-2/ARNO (WT and E156K) showed high colocalization (Supplemental Table S1). To resolve cytohesin-2/ARNO-EHD1 colocalization at tubular endosomes, we allowed cytosolic cytohesin-2/ARNO to leak out by permeabilizing cells using saponin before fixation. In saponin-treated cells, both WT-ARNO ([Figure 1, D and E](#F1){ref-type="fig"}) and E156K-ARNO ([Figure 1, F and G](#F1){ref-type="fig"}) showed high colocalization (Supplemental Table S1) of cytohesin-2/ARNO with EHD1 on tubular endosomes. Of interest, in cells in which Cerulean-EHD1 was expressed alone, saponin concentrations of 0.02% led to complete loss of EHD1 in most cells (Supplemental Figure S1A). Cells treated with 0.02% saponin that were able to retain EHD1 showed a much more diffusely distributed EHD1. These data confirm a previous finding showing EHD1 sensitivity to digitonin permeabilization ([@B5]) and suggest that cytohesin-2/ARNO may aid in stabilizing EHD1 on the membrane. Taken together, these data suggest a previously unknown role for cytohesin-2/ARNO in regulating recycling at the ERC.

Because E156K-ARNO expression increases intracellular accumulation of EHD1, we sought to measure this accumulation using microscopy and masking techniques. We applied a two dimensional (2D) Laplacian filter to the EHD1 channel, which allowed us to resolve EHD1 endosomes throughout all areas of the cell. We masked these EHD1 endosomes and asked which samples had more EHD1 endosomal area (μm^2^) per whole-cell area (μm^2^/μm^2^). We noticed that HeLa cells expressing E156K-ARNO had significantly more EHD1 area per whole-cell area than the other samples ([Figure 1H](#F1){ref-type="fig"}). Of importance, raw endosomal area did not differ greatly from each sample when whole-cell area was not considered (Supplemental Figure S1B). Although we did see more EHD1 endosomal area in WT-ARNO cells compared with E156K-ARNO cells (*p* = 0.022), this is not surprising, considering that cells on average are ∼50% more spread. Taken together, these data demonstrate that cytohesin-2/ARNO colocalizes with ERC marker EHD1 and GEF activity of cytohesin-2/ARNO can affect the morphology of EHD1 recycling endosomes.

Wild-type, constitutively active (38V), but not dominant-negative (43N), R-Ras colocalizes with EHD1 tubular endosomes
----------------------------------------------------------------------------------------------------------------------

Colocalization of R-Ras with recycling endosomal markers (i.e., Rab11) has been widely reported ([@B10]; [@B51]; [@B56]), and EHD1 has been associated with β1-integrin recycling and cell spreading ([@B27]). To our knowledge, no one has investigated whether R-Ras associates with EHD1-positive endosomes. Although HeLa cells express R-Ras endogenously ([@B17]), immunofluorescence staining of endogenous R-Ras has been mostly uninformative. Therefore we began by transiently coexpressing mCherry-tagged WT, constitutively active (38V), and dominant-negative (43N) R-Ras with Cerulean-EHD1 in HeLa cells plated on fibronectin. WT and 38V R-Ras colocalized (Supplemental Table S2) with EHD1 tubules and peripheral pools of plasma membrane EHD1 ([Figure 2, A and B](#F2){ref-type="fig"}). EHD1 tubular endosomes, particularly in 38V-expressing cells, had a beaded or fragmented appearance. Despite sharing a similar colocalization value, the bulk of 43N R-Ras was noticeably absent from EHD1 tubules ([Figure 2C](#F2){ref-type="fig"}). Occasionally EHD1 appeared as doughnut-shaped structures surrounding 43N R-Ras puncta. HeLa cells coexpressing EHD1 and 43N R-Ras still showed tubule formation, and average tubule length did not vary significantly among cells coexpressing EHD1 with WT, 38V, or 43N R-Ras (Supplemental Figure S2). Although it is unclear what these doughnut-shaped EHD1/43N R-Ras structures are, this is the most significant level of colocalization that 43N R-Ras has had with any endosomal marker. These data suggest that activation of R-Ras is required for its association with EHD1-positive tubules and not for formation of tubular endosomes per se, at least in cells overexpressing EHD1.

![EHD1-positive recycling endosomes are compartments for active R-Ras. (A--C) HeLa cells were Neon transfected using Cerulean-EHD1 or mCherry WT R-Ras (A), constitutively active mCherry 38V R-Ras (B), or dominant-negative mCherry 43N R-Ras (C). Cells were allowed to express overnight on fibronectin-coated coverslips. The next day, cells were fixed and imaged using wide-field microscopy. White boxes on whole-cell images show representative cropped regions. Whereas WT and 38V R-Ras localize to EHD1 tubules, the bulk of 43N R-Ras is not with EHD1 tubules. Instead, EHD1 surrounds 43N R-Ras. White arrowheads show tubules. In the merged images, EHD1 is pseudocolored cyan and R-Ras is red. Images were deconvolved using SlideBook 6.0. Scale bars, 20 μm.](4265fig2){#F2}

To characterize further the R-Ras trafficking itinerary, we coexpressed EHD1 and R-Ras with Rab8a and Rab11a, which are small GTPases involved in recycling. Because Rab8a and EHD1 are intimately associated in the formation of the ERC ([@B45]; [@B76]), we hypothesized that R-Ras should also be associated with Rab8a. Indeed, Rab8a colocalized with 38V R-Ras (Supplemental Figure S3A) on EHD1 tubules and at the peripheral plasma membrane (Supplemental Figure S3, B and C). However, 43N R-Ras did not colocalize with Rab8a or Rab11a and did not form similar doughnut structures with Rabs as we saw with EHD1 (Supplemental Figure S3, D, E, I, and J). Constitutively active R-Ras partially localized with Rab11a (Supplemental Figure S3F) on tubular endosomes but not at the plasma membrane (Supplemental Figure S3, G and H). Therefore R-Ras has a stronger association to EHD1/Rab8a than Rab11a. These findings show that R-Ras traffics through an EHD1-positive ERC and that activation of R-Ras is required for its proper trafficking through EHD1 endosomes.

E156K-ARNO--expressing cells show an accumulation of 38V R-Ras at EHD1-positive endosomes
-----------------------------------------------------------------------------------------

Because our data show that cytohesin-2/ARNO colocalizes and affects the morphology of EHD1-positive endosomes, we wondered whether we could trap R-Ras at EHD1 endosomes by specifically abrogating the GEF activity of cytohesin-2/ARNO. We reasoned that the GEF-activity of cytohesin-2/ARNO could promote R-Ras dependent spreading by 1) activating ARF at the plasma membrane and regulating endocytosis of R-Ras or 2) activating ARF on EHD1 endosomes, which would promote recycling to the plasma membrane. If cytohesin-2/ARNO is regulating endocytosis, we should see the bulk of R-Ras stuck at the plasma membrane if GEF-activity is destroyed. If cytohesin-2/ARNO--induced ARF activation is required for R-Ras recycling, we should see high levels of intracellular R-Ras, perhaps trapped on EHD1 recycling endosomes. HeLa cells expressing Venus 38V R-Ras with WT mCherry-ARNO and Cerulean-EHD1 showed punctate EHD1 distribution, with all three proteins enriched at the peripheral plasma membrane ([Figure 3, A and B](#F3){ref-type="fig"}). In contrast, cells with mCherry E156K-ARNO showed intracellular accumulation of 38V R-Ras on EHD1-positive endosomes ([Figure 3, C and D](#F3){ref-type="fig"}). In many cases, these endosomes were long tubes, on average ∼2.5 times the length of EHD1 endosomes found in cells expressing WT-ARNO (Supplemental Figure S4). These data show that even in the presence of a constitutive upstream R-Ras signal, active R-Ras requires a functional cytohesin-2/ARNO for proper recycling and localization to the peripheral plasma membrane.

![GEF-inactive E156K-ARNO causes an accumulation of 38V R-Ras on EHD1-positive endosomes. (A--D) HeLa cells were transiently transfected using Neon electroporation and allowed to express overnight on fibronectin-coated coverslips. Cerulean-EHD1, Venus 38V R-Ras, and either mCherry WT-ARNO (A, A′, B, B′) or GEF-inactive mCherry E156K-ARNO (C, C′, D, D′) were used for transfection. Cells were imaged as previously described. Expression of WT-ARNO distributed EHD1 and 38V R-Ras along the peripheral plasma membrane (A′), and 38V R-Ras was seen in small, EHD1-positive endosomes (B′). Expression of E156K-ARNO caused an accumulation of 38V R-Ras on long EHD1 tubules, away from the periphery (C′, D′). Whole-cell views are shown in A--D, where white boxes represent regions of interest shown in A′--D′. White arrows show tubules. In the merged images, EHD1 is pseudocolored cyan, R-Ras is yellow, and ARNO is red. Scale bars, 20 μm.](4265fig3){#F3}

Knockdown of cytohesin-2/ARNO causes intracellular accumulation of R-Ras and EHD1
---------------------------------------------------------------------------------

We reasoned that if destroying the GEF function of cytohesin-2/ARNO prevents ARF-induced recycling of components on the ERC, then knockdown of cytohesin-2/ARNO should mimic the effects of E156K-ARNO. In an endogenous cytohesin-2/ARNO background, overexpression of EHD1 alone results in significant tubule formation. However, there is a dramatic difference in EHD1 morphology among cells in which WT-ARNO is expressed versus GEF-inactive ARNO. Therefore we wondered whether reducing endogenous cytohesin-2/ARNO could cause a build-up effect in cells expressing EHD1 and R-Ras. To this end, we transfected HeLa cells with universal control small interfering RNA (siRNA) or siRNA targeting human cytohesin-2/ARNO. The next day, recovered cells were cotransfected using Cerulean-EHD1 and Venus R-Ras, and they were allowed to express overnight. We were able to reduce endogenous cytohesin-2/ARNO levels by 75% without altering the levels of cytohesin-3/general receptor for phosphoinositides-1 (GRP1), another ubiquitously expressed cytohesin (Supplemental Figure S5A). When we imaged HeLa cells coexpressing WT or 38V R-Ras with EHD1, we found that control cells showed EHD1 and R-Ras distributed in small, punctate endosomes or small, tubular endosomes ([Figure 4, A and D](#F4){ref-type="fig"}). In contrast, knockdown of cytohesin-2/ARNO led to perinuclear accumulation of R-Ras and EHD1 ([Figure 4, B and E](#F4){ref-type="fig"}). Particularly in 38V R-Ras--expressing cells, tube formation was so extensive that individual tubules were difficult to visualize. To measure intracellular accumulation, we applied the same masking techniques used previously. We again found significantly higher levels of endosomal area per whole-cell area of both EHD1 and R-Ras ([Figure 4, C and F](#F4){ref-type="fig"}). Cells expressing 38V R-Ras showed higher accumulation of EHD1 and R-Ras where cytohesin-2/ARNO levels were reduced. It is possible that 38V R-Ras traffics faster onto tubular compartments at a higher rate than WT R-Ras, causing a more noticeable build-up over time. We hypothesized that because 43N R-Ras was unable to associate with EHD1-positive endosomes, cytohesin-2/ARNO knockdown should have no effect on its intracellular accumulation. When we measured 43N R-Ras accumulation, there was no significant difference between control and cytohesin-2/ARNO--knockdown cells (Supplemental Figure S5B, right graph). Of interest, cytohesin-2/ARNO knockdown still caused extensive EHD1 accumulation in cells expressing 43N R-Ras (Supplemental Figure S5, C and D). These data suggest that cytohesin-2/ARNO knockdown only inhibits trafficking of R-Ras that can arrive at the ERC.

![Knockdown of cytohesin-2/ARNO causes internal accumulation of EHD1 and R-Ras. Negative control siRNA (Invitrogen) or siRNA targeting human ARNO was transfected into HeLa cells using Neon electroporation. The next day, cells were transfected using Lipofectamine3000 (Life Technologies) with Cerulean-EHD1 and Venus WT R-Ras (A, B) or Venus 38V R-Ras (D, E) and allowed to express overnight to achieve 48 h of knockdown. Cells were fixed and imaged as previously described. We applied 2DLaplacian filtering to raw images to resolve endosomes using SlideBook 6.0 software. Filtered channels were masked for endosomal area, and nonfiltered channels were masked for whole-cell area. Normalized endosomal area per whole-cell area is shown (C, F). The following numbers of cells from one experiment were analyzed: 134 for EHD1/WT R-Ras control and ARNOsi and 140 for EHD1/38V R-Ras control and ARNOsi. Samples were analyzed using a two-sample *t* test using MiniTab 17. \*\*\**p* \< 0.001. Scale bars, 20 μm.](4265fig4){#F4}

We noticed that increased intracellular accumulation of EHD1 as a result of cytohesin-2/ARNO knockdown manifests as enhanced tubule formation. Although our masks were able to measure total EHD1 accumulation, we wanted confirm that cytohesin-2/ARNO siRNA-treated cells contained more endosomes of larger size. To this end, we extracted morphometry parameters for endosomal perimeter and major axis length from our EHD1 masks. For each image analyzed, we calculated the percentage of endosomes that were within a certain micrometer range. Consistently, cytohesin-2/ARNO knockdown caused an increase in the percentage of endosomes with large (\>10 μm) perimeter and large major axis length (\>8 μm; Supplemental Table S3). Control cells typically contained higher percentages of smaller endosomes than knockdown cells. These data show that cytohesin-2/ARNO knockdown increases levels of intracellular EHD1/R-Ras on tubular endosomes.

As performed similarly for the double-transfectant cells, we analyzed single transfectants (expressing solely EHD1 or R-Ras). We saw an increase in intracellular EHD1, WT, and 38V R-Ras (Supplemental Figure S6, A, D, and G). Consistent with what was observed with the double transfectants, levels of intracellular 43N R-Ras did not change (Supplemental Figure S6J). Endosomal-like structures containing Venus WT or 38V R-Ras occasionally displayed a tubular morphology strikingly similar to the ERC when expressed alone without EHD1 (Supplemental Figure S6, E and H). In agreement with our previous observations, expression of Venus 43N-R-Ras was never found in tubular endosomes and displayed its typical, punctate, and highly intracellular morphology in control and cytohesin-2/ARNO--knockdown cells (Supplemental Figure S6, K and L). These data support the idea that cytohesin-2/ARNO is required for R-Ras recycling from the ERC.

Intracellular accumulation of both EHD1 and R-Ras corresponds to a reduction of short- and long-term cell spreading
-------------------------------------------------------------------------------------------------------------------

If disrupting the GEF activity of cytohesin-2/ARNO inhibits R-Ras recycling and prevents its localization to the plasma membrane, then R-Ras--dependent effects on cell spreading should be inhibited. We returned to previous experiments and measured the whole-cell area of cells transfected with Cerulean-EHD1 or in combination with cytohesin-2/ARNO from [Figure 1](#F1){ref-type="fig"}. We found that WT cytohesin-2/ARNO enhanced spreading of HeLa cells plated on fibronectin-coated coverslips compared with both EHD1- and EHD1/E156K-expressing cells ([Figure 5A](#F5){ref-type="fig"}). Even when allowed to spread overnight in an endogenous cytohesin-2/ARNO background, E156K-ARNO still inhibited cells from spreading to levels of EHD1-expressing cells. We observed a similar effect on long-term cell spreading in cells in which we saw 38V R-Ras trapped with EHD1 ([Figure 5B](#F5){ref-type="fig"}). Finally, we asked whether cytohesin-2/ARNO knockdown could also reduce cell spreading in actively spreading HeLa cells even when R-Ras is overexpressed. We transfected HeLa cells with Turquoise LifeAct or Venus 38V R-Ras alone. We then inhibited cytohesin-2/ARNO using siRNA-mediated knockdown, expression of E156K-ARNO, or pharmacologically, using SecinH3 ([@B21]). Cells were nonenzymatically harvested, seeded onto fibronectin-coated coverslips, and allowed to spread for 35 min before fixation. Cells transfected with siRNA targeting cytohesin-2/ARNO (80% knockdown; Supplemental Figure S7) showed a drastic reduction in cell area in both LifeAct and 38V R-Ras--expressing cells ([Figure 5C](#F5){ref-type="fig"}). Spreading was reduced to levels comparable to cytohesin-2/ARNO knockdown whether cells were treated with SecinH3 or cotransfected with E156K-ARNO. In 38V-expressing cells, in which cytohesin-2/ARNO was inhibited, we noticed that despite adhering more quickly than cells expressing LifeAct, they ultimately failed to spread. In these cells, 38V R-Ras was highly accumulated near the center of spreading cells away from the periphery in punctate-to-tubular structures ([Figure 5D](#F5){ref-type="fig"}). In cells treated with control siRNA, 38V R-Ras was found at the outer cell edges in typical ruffle-like structures. Our data suggest that a functional cytohesin-2/ARNO is required for a full spreading response in HeLa cells.

![Internal accumulation of R-Ras caused by GEF-inactive cytohesin-2/ARNO correlates with inhibited cell spreading. Whole-cell area was measured in cells from [Figure 1](#F1){ref-type="fig"} (A) and [Figure 3](#F3){ref-type="fig"} (B). (C) Cells were transfected with universal negative control siRNA (Invitrogen) or siRNA targeting human ARNO. The next day, cells were transfected with Lipofectamine 3000 containing the constructs shown. After 48 h, cells were nonenzymatically harvested and seeded onto fibronectin-coated coverslips. Cells were fixed after 35 min of spreading. Whole-cell area was measured using SlideBook 6.0. (D) Representative images of cells close to the average area. The LifeAct channel is shown for control cells, and the R-Ras channel is shown for 38V R-Ras--expressing cells. Samples were analyzed from one experiment using cell numbers 99 for LifeAct control, 96 for 38V R-Ras, 94 for SecinH3 treated, and 74 for E156K expressing. (E) Cells were nonenzymatically harvested and allowed to spread for 20 min on fibronectin-coated coverslips. (LifeAct Cont, 94 cells; LifeAct R-Ras si, 103 cells; ARNO Cont, 88 cells; and ARNO R-Ras si, 119 cells). Measurement from one experiment for statistical significance was done in MiniTab17 using a two-sample *t* test. \*\*\**p* \< 0.001, \*\**p* \< 0.01, ns, not significant.](4265fig5){#F5}

To show directly that R-Ras is required for cell spreading, we measured how well HeLa cells could spread on fibronectin in cells in which R-Ras was knocked down. R-Ras siRNA-- treated cells showed a significant reduction in short-term cell spreading in cells expressing LifeAct ([Figure 5E](#F5){ref-type="fig"}). We then tested the ability of cytohesin-2/ARNO overexpression to rescue spreading in R-Ras siRNA--treated cells. Cytohesin-2/ARNO overexpression was not able to enhance cell spreading in cells in which R-Ras levels were reduced. Taken together, these data demonstrate that both cytohesin-2/ARNO and R-Ras are required for cell spreading in HeLa cells.

E156K cytohesin-2/ARNO reduces focal adhesion size in HeLa cells
----------------------------------------------------------------

R-Ras has cell type--specific effects on focal adhesion formation. In HeLa cells, focal adhesions are sites for active R-Ras, and R-Ras is required for focal adhesion formation ([@B17]). Dominant negative (43N) R-Ras does not localize with focal adhesions and reduces the size of focal adhesions in HeLa cells when it is expressed. A reduction in focal adhesion size suggests that integrin and/or R-Ras is not being trafficked to specific sites of need to established cell-ECM contacts. We reasoned that the GEF activity of cytohesin-2/ARNO would be required to properly localize R-Ras and therefore would phenocopy effects that expression of 43N R-Ras has on focal adhesions ([@B17]). When we transfected HeLa cells with mCherry E156K-ARNO and stained for endogenous β1-integrin, cells showed significantly smaller focal adhesions than with LifeAct control cells or WT-ARNO--expressing cells ([Figure 6A](#F5){ref-type="fig"}). In addition, the overall number of focal adhesions per cell decreased in cells expressing E156K-ARNO ([Figure 6B](#F6){ref-type="fig"}). Control HeLa cells expressing Turquoise LifeAct to label F-actin showed large focal adhesions throughout the entire cell ([Figure 6C](#F6){ref-type="fig"}). In contrast, E156K-ARNO cells had a noticeable absence of ventral adhesions and smaller peripheral adhesions ([Figure 6D](#F6){ref-type="fig"}), very similar to what was reported with 43N R-Ras in HeLa cells ([@B17]). Cells expressing WT cytohesin-2/ARNO could still produce large focal adhesions but also had a distinct population of β1-integrin all along the cell periphery ([Figure 6E](#F6){ref-type="fig"}). We also saw a statistically significant (*p* = 0.047) reduction in the number of focal adhesions compared with control cells. Cytohesin-2/ARNO overexpression could result in rapid turnover of focal adhesions, thus decreasing the overall number. Most of the larger adhesions in WT-ARNO cells were found closer to the peripheral plasma membrane, in contrast to LifeAct controls, which had focal adhesions throughout the whole area of the cell. These data support a model in which cytohesin-2/ARNO is required to properly localize R-Ras to establish R-Ras--dependent effects on spreading and focal adhesion formation.

![Expression of E156K-ARNO causes a reduction in focal adhesion size and number. Cells were transfected with Turquoise LifeAct, mCherry WT-ARNO, or mCherry E156K-ARNO and subsequently stained for endogenous β1-integrin (Alexa 488 secondary antibody was used for ARNO-transfected cells; Alexa 594 was used for LifeAct controls). (A, B) β1-Integrin channels were masked to highlight focal adhesions, and the area (A) and number (B) of those objects was exported using SlideBook 6.0 (LifeAct, 31 cells; mchE156K-ARNO, 33 cells; mchWT-ARNO, 24 cells). (C--E) Representative images showing focal adhesion distribution. Left, immunostained endogenous β1-integrin. Right, LifeAct control (C), E156K-ARNO (D), or WT-ARNO (E). Yellow arrows show large adhesions; red arrows show small adhesions. Measurement from one experiment for statistical significance was done in MiniTab17 using a two-sample *t* test. \*\*\**p* \< 0.001, \**p* \< 0.05; ns, not significant.](4265fig6){#F6}

Disruption of R-Ras/ARNO signaling blocks serum-stimulated α5-integrin recycling and peripheral plasma membrane localization of R-Ras
-------------------------------------------------------------------------------------------------------------------------------------

We previously showed that cytohesin-2/ARNO is required for stimulated β1-integrin recycling, cell spreading, and migration ([@B38], [@B39]). Given that R-Ras functions in promoting recycling and proper distribution of integrin, namely β1 ([@B10]), and EHD1 is required for β1-integrin recycling, spreading, and migration ([@B27]), we wondered whether blockage of the R-Ras/ARNO signaling module could inhibit integrin and R-Ras recycling to the plasma membrane. R-Ras/ARNO signaling was inhibited three different ways in cells expressing a Venus-tagged α5-integrin: by expressing 43N R-Ras or E156K-ARNO or treating cells with the cytohesin inhibitor SecinH3. Because we used an antibody that recognizes active β1, we could confirm that R-Ras and active β1 are both found at the plasma membrane after serum stimulation. Cells expressing Turquoise WT R-Ras showed high intracellular R-Ras, which highly localized with α5-integrin before serum stimulation ([Figure 7A](#F7){ref-type="fig"}; 0 min). After 5 min of serum stimulation, WT R-Ras was seen at the plasma membrane with Venus α5-integrin ([Figure 7A](#F7){ref-type="fig"}, 5 min). At 15 min, some cells displayed plasma membrane-- localized R-Ras and α5-integrin all around the cell periphery ([Figure 7A](#F7){ref-type="fig"}, 15 min). When WT R-Ras was substituted with 43N R-Ras, cells no longer responded to serum. Punctate 43N R-Ras colocalized with α5β1-integrin puncta at 0, 5, and 15 min ([Figure 7B](#F7){ref-type="fig"}). Remarkably, stimulated recycling of integrin and R-Ras was also inhibited in cells treated simultaneously with serum and cytohesin inhibitor SecinH3 ([Figure 7C](#F7){ref-type="fig"}). Although SecinH3 inhibits all cytohesins, we have shown that cytohesin-3/GRP1 has opposing effects on spreading and migration and that GRP1 is nonessential for β1-integrin recycling ([@B38]). Expression of E156K-ARNO phenocopies SecinH3 treatment and blocks stimulated recruitment of R-Ras ([Figure 7D](#F7){ref-type="fig"}). Surprisingly, very few cells contained significant amounts of R-Ras in tubules. We believe that the permeabilization required for antibody staining dissolves EHD1 tubes in most cells. In summary, R-Ras/ARNO signaling is specialized for stimulated recycling of α5-integrin, whether by serum induction or spreading on fibronectin matrix.

![Blockage of the R-Ras/ARNO signaling module inhibits serum-stimulated recycling of R-Ras and α5-integrin to the plasma membrane. Transfected HeLa cells plated on fibronectin-coated coverslips were allowed to recover in normal growth medium with serum for 5 h. Serum-free medium was added to recovered cells overnight. The next day, HeLa cells were treated with warm medium containing 0% serum (time 0) or 20% serum for 5 and 15 min. After the indicated time, cells were fixed and stained for endogenous β1-integrin. SecinH3, 15 μM, was added at the same time as 20% serum shock. Equal amounts of DMSO were added to all other samples. In the merged images, R-Ras is pseudocolored cyan, α5-integrin is green, 594 and 647 β1-integrin are red, and E156K-ARNO is magenta. WT R-Ras control, 111 cells; 43N R-Ras, 42 cells; Secin-treated cell, 67 cells; E156K expressing, 108 cells. Scale bars, 10 μm.](4265fig7){#F7}

To establish EHD1-positive endosomes as a compartment for α5-integrin and cytohesin-2/ARNO as a regulator of the α5-integrin recycling, we used siRNA targeting endogenous cytohesin-2/ARNO and asked whether we could rescue serum-stimulated recycling of α5-integrin by expressing mCherry WT-ARNO. At time 0, both WT-ARNO-- and E156K-ARNO--expressing cells showed high perinuclear distribution of EHD1 and α5-integrin ([Figure 8, A](#F8){ref-type="fig"} and [B](#F8){ref-type="fig"}). After 1 and 5 min of serum treatment, α5-integrin and EHD1 reorganized away from the perinucleus and diffused toward the cell periphery in cells expressing WT-ARNO ([Figure 8A](#F8){ref-type="fig"}). However, in cells expressing E156K-ARNO, α5-integrin and EHD1 remained highly intracellular and perinuclear ([Figure 8B](#F8){ref-type="fig"}). Taken together, these data demonstrate that R-Ras and α5β1-integrin recycle through an EHD1-positive compartment under control of cytohesin-2/ARNO.

![GEF-inactive E156K-ARNO inhibits α5-integrin recycling upon serum stimulation. HeLa cells were subjected to Neon electroporation to knock down endogenous cytohesin-2/ARNO and seeded onto fibronectin-coated coverslips. After 16 h of knockdown, cells were transiently transfected with constructs expressing Cerulean-EHD1, Venus-α5-integrin, and siRNA-resistant mCherry WT-ARNO (A) or GEF-inactive mCherry siRNA-resistant E156K-ARNO (B) and were allowed to express the proteins for 24 h. The next day, cells were treated with 20% FBS for 0, 1, or 5 min to stimulate integrin recycling and viewed under a wide-field microscope. In the merged images, EHD1 is pseudocolored cyan, α5-integrin is yellow, and ARNO is red. WT-ARNO cells analyzed, 67; E156K cells analyzed, 133. Scale bars, 10 μm.](4265fig8){#F8}

DISCUSSION
==========

A clear model of how R-Ras promotes cell spreading and adhesion has remained elusive due to our limited understanding of how R-Ras traffics. Here we established EHD1-positive endosomes as a novel compartment for cytohesin-2/ARNO and R-Ras. We showed that cytohesin-2/ARNO is required for R-Ras recycling through the ERC and for effects of R-Ras on cell spreading and focal adhesion formation. Spreading defects caused by R-Ras knockdown cannot be rescued by cytohesin-2/ARNO overexpression. Finally, cytohesin-2/ARNO is required for serum-stimulated peripheral plasma membrane localization of R-Ras and α5-integrin.

The use of a GEF-inactive mutant of cytohesin-2/ARNO gave us a unique ability to establish a connection between cytohesin-2/ARNO, EHD1, and R-Ras. Expression of a GDP-locked mutant of ARF6 has been shown to disrupt formation of the EHD1 compartment itself ([@B6]) and thus would likely not phenocopy the effects of E156K-ARNO on EHD1 endosomes. We believe there are several possible mechanisms to explain how E156K-ARNO inhibits R-Ras recycling and causes a build-up of R-Ras/EHD1 internally. Our images of permeabilized cells ([Figure 1](#F1){ref-type="fig"}) suggest that there is recruitment of WT- and E156K-ARNO onto endosomal membranes containing EHD1. Thus E156K-ARNO would be in a position to associate with ARF-GDP but fails to perform the exchange reaction, thus preventing exocytosis from EHD1-positive endosomes and recycling back out to the plasma membrane ([@B3]; [@B71]). In addition, cytohesins function through a positive feedback loop by which autoinhibition is relieved by associating with ARF-GTP through their PH domains ([@B11]; [@B77]). Expression of E156K-ARNO could in turn reduce the levels of cytohesin-2/ARNO that are relieved of autoinhibition and thus recruited onto membrane. Depletion of peripheral ARF1-GTP and ARF6-GTP by E156K-ARNO likely inhibits recycling of R-Ras, as well as cell spreading. Cytohesin-2/ARNO is a more efficient GEF for ARF1, and ARF6 binds more strongly to the PH domain of cytohesin-2/ARNO to allow for membrane recruitment ([@B9]). Indeed, expression of dominant-negative ARF1 prevents full spreading rescue when R-Ras effector RLIP76 is knocked down ([@B20]). RLIP76 has been shown to associate directly with cytohesin-2/ARNO ([@B33]) and could aid in directly recruiting cytohesin-2/ARNO onto membrane tubules. No one has investigated whether RLIP76 traffics through the ERC.

Knockdown of R-Ras or expression of dominant-negative R-Ras has been shown by several groups to inhibit cell spreading, migration, and adhesion ([@B55]; [@B20]; [@B46]; [@B56]). Our data show that spreading deficiencies caused by R-Ras knockdown cannot be rescued by cytohesin-2/ARNO while cells are actively spreading. We also demonstrate that R-Ras must be activated to associate with EHD1-positive endosomes at the ERC. Thus our model provides two key steps required for R-Ras-dependent spreading and adhesion formation ([Figure 9](#F9){ref-type="fig"}): 1) R-Ras must be activated to reach EHD1-positive endosomes ([Figure 9](#F9){ref-type="fig"}, \#1) and 2) the GEF-activity of cytohesin-2/ARNO is required for R-Ras/integrin recycling ([Figure 9](#F9){ref-type="fig"}, \#2). It is conceivable that R-Ras activation may be required to reach any endosomal compartment, as dominant-negative R-Ras has only been shown to localize with dominant-negative ARF6 puncta ([@B17]) and, to our knowledge, no other Rab markers. This could explain why 43N R-Ras wobbles back and forth in no particular direction in live cells ([@B56]) and its localization is not affected by cytohesin-2/ARNO knockdown.

![Model of cytohesin-2/ARNO--dependent recycling of R-Ras. R-Ras/integrins are internalized, perhaps through a noncytohesin ARF-GEF (i.e., BRAG2), and traffic to Rab5 early endosomes. Active R-Ras is recruited onto an EHD1-positive ERC compartment that contains integrin and cytohesin-2/ARNO (1). Cytohesin-2/ARNO-induced ARF-activation is required for exocytosis of R-Ras from the ERC (2). Peripherally localized R-Ras is able to enhance cell spreading and establish adhesions.](4265fig9){#F9}

This and previous studies ([@B38], [@B39]) establish a role for cytohesin-2/ARNO in the recycling of integrins. EHD1 is required for β1-integrin recycling and turnover of focal adhesions ([@B27]). Of interest, migration of mouse embryonic fibroblasts isolated from EHD1-knockout mice is inhibited on fibronectin matrix. However, on vitronectin, which is recognized by β3-integrin ([@B26]), EHD1 levels do not change the migration efficiency ([@B27]). Immunofluorescence experiments performed in this study used cells plated on fibronectin, which is recognized by α5β1-integrin receptors. GEF-inactive cytohesin-2/ARNO causes a perinuclear accumulation of α5-integrin in serum-stimulated cells. Thus we support a model in which EHD1/ARNO controls recycling of integrin heterodimers containing β1. BRAG2, also a GEF for ARF6, has been shown to regulate β1-integrin endocytosis in HeLa cells ([@B13]). Cytohesin-2/ARNO and BRAG2 may work in concert by regulating integrin recycling and internalization, respectively ([@B13]).

The mechanism by which cytohesin-2/ARNO dually controls integrin and R-Ras recycling is not clear. In our model, cytohesin-2/ARNO recycles R-Ras to areas where it is needed. However, a possible function of R-Ras might be to chaperone integrin to the ERC, such that cytohesin-2/ARNO can recycle both components concurrently. We showed in serum-stimulated cells that dominant-negative R-Ras localizes with high levels of α5-integrin in immunostained cells ([Figure 7](#F7){ref-type="fig"}). The reduction in focal adhesion size caused by E156K-ARNO ([Figure 6](#F6){ref-type="fig"}) is most likely due to inhibition of R-Ras and β1-integrin recycling. A similar phenotype has been demonstrated when expressing 43N R-Ras in HeLa cells ([@B17]). In different cell types, others have proposed that R-Ras does not regulate the recycling of total integrin to the plasma membrane ([@B10]; [@B46]) but instead the endocytosis of activated integrin ([@B46]). Therefore cytohesin-2/ARNO--induced ARF-activation could be required to recycle R-Ras to integrin-enriched sites near the plasma membrane.

Future experiments are needed to determine the role of R-Ras/ARNO in the activation of Rac1 in epithelial cells. Both Rac1 and Rho play important roles in establishing focal complexes and focal adhesions ([@B37]; [@B73]). We showed that cytohesin-2/ARNO associates with the scaffolding protein GRASP, which directly recruits DOCK180 ([@B1]). This interaction is required for cytohesin-2/ARNO--induced Rac1 activation and migration ([@B48]; [@B53]). If the coiled-coil domain is deleted, cytohesin-2/ARNO can still activate ARF6, but Rac1 is not activated, and thus migration is inhibited ([@B53]). Therefore, even if R-Ras is efficiently recycled through ARF6-GTP, Rac1 activation would still be required to establish cell--extracellular matrix adhesions.

R-Ras may directly or indirectly stimulate the GEF activity of cytohesin-2/ARNO. RLIP76 binds R-Ras-GTP ([@B20]) and interacts with cytohesin-2/ARNO to stimulate ARF6 and Rac1 activation ([@B33]). In fibroblasts, cytohesin-2/ARNO overexpression has been shown to rescue cell spreading in cells in which endogenous RLIP76 is reduced ([@B20]). Similarly, RLIP76 overexpression can rescue cell spreading and ARF6 activation in cells expressing dominant-negative R-Ras. Thus cytohesin-2/ARNO functions downstream of R-Ras/RLIP76. R-Ras, and cytohesin-2/ARNO may not perform in a direct linear pathway in HeLa cells. Intriguingly, R-Ras localizes to focal adhesions in HeLa cells ([@B17]) but not fibroblasts ([@B56]). In support of this model, MDCK epithelial cells overexpressing cytohesin-2/ARNO fail to activate Rac1 and migrate when GRASP or CNK3/IPCEF1 levels are reduced ([@B53]). It is tempting to speculate that the other cytohesin-2/ARNO--binding proteins, such as CNK3/IPCEF1, could interact with RLIP76 to regulate migration in epithelial cells. Future studies will need to determine how these factors come together to form a signaling module.

MATERIALS AND METHODS
=====================

Antibodies and reagents
-----------------------

TS2/16 anti--β1 integrin antibody was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Alexa Fluor--conjugated anti-mouse secondary antibodies (488, 594, 647) were from Jackson ImmunoResearch Laboratories (West Grove, PA). SecinH3 was purchased from EMD Millipore (Billerica, MA). Human fibronectin matrix was obtained from Corning (Corning, NY).

Plasmid constructs
------------------

Myc-tagged human R-Ras WT and mutant (38V and 43N) were a gift from L. E. Goldfinger (Temple University School of Medicine, Philadelphia, PA). Primers were designed to clone myc-R-Ras into pCXN2 mammalian expression vector containing the gene for mCherry, Venus, or Turquoise fluorescent tags. R-Ras constructs were cloned using the primers NotRRasRev (5-CTGGATGCGGCCGCTCATCACTACAGGAGGACGCAGGGGCA-3′) and either KpnMycRRasWT (5-GGTACCGCCACCATGGAACAAAAACTAATATCGGAAGAAGATCTA-3′) for WT R-Ras or KpnMycFwd (5-CACGGGGTACCGCCACCATGGAGCAGAAGCTGATCTCC-3′) for mutant R-Ras. Cerulean-EHD1, Venus Rab8a, and Venus Rab11a constructs were a gift from Jim Goldenring (Vanderbilt University, Nashville, TN). Human GFP α5-integrin (plasmid 15238; deposited by Rick Horwitz from the University of Virginia, Charlottesville, VA; [@B32]) and Turquoise LifeAct (plasmid 36201; deposited by Dorus Gadella from the University of Virginia; [@B19]) were purchased from AddGene (Cambridge, MA). α5-integrin was excised from its original vector using *Kpn*I and ligated into pCDNA3 with a C-terminal Venus tag. Control and siRNA-resistant versions of mCherry WT-ARNO and mCherry E156K-ARNO have been previously described ([@B39]).

Cell lines
----------

HeLa cells were maintained in DMEM supplemented with 10% fetal bovine serum, 1% penicillin, streptomycin, and Fungizone, and 2 mM [l]{.smallcaps}-glutamine. HeLa cells were cultured at 37°C and 5% CO~2~.

siRNA-mediated knockdown
------------------------

siRNA duplexes targeting the sequence 5-GCAAUGGGCAGGAAGAAGU-3 targeting human cytohesin 2/ARNO were purchased from Dharmacon (Lafayette, CO), and negative universal control siRNA (46-2002) was purchased from Invitrogen (Carlsbad, CA). Human R-Ras siRNA pool was purchased from Dharmacon (M-010352-02). The siRNAs (200 nM) were transfected into 1 × 10^6^ HeLa cells by using a Neon Transfection System (Invitrogen) according to the manufacturer\'s recommended protocol (1005 V, 35 ms, 2x). Altogether, 1 × 10^5^ cells were plated on square coverslips coated with fibronectin.

Immunofluorescence and image analysis
-------------------------------------

All HeLa cells were plated on flame-sterilized, fibronectin-coated (EMD Millipore) coverslips (20 μg/ml) and mounted using Prolong Gold Antifade reagent (Life Technologies). Microscopic images were taken using an Olympus IX83 inverted microscope (Tokyo, Japan) equipped with SlideBook 6.0 software (Intelligent Imaging Innovations, Denver, CO) for image analysis. To assess EHD1 tube formation in SlideBook 6.0, raw images were treated with a 2D Laplacian filter to resolve endosomes. EHD1 channels were masked to include intracellular EHD1 endosomes. Nonendosomal areas (i.e., cell debris and spiked protrusions) were erased from masks on all images. For ARNO-knockdown experiments, masks were gated to exclude objects \<0.5 μm^2^ (43N R-Ras masks were exported with 0.1-μm^2^ gating), and the internal masked endosomal area (square micrometers) was exported. Whole-cell area (square micrometers) was generated by masking an unfiltered channel. To assess the amount of internal EHD1, the filtered EHD1 endosomal area was divided by the whole-cell area. For morphometry analysis, the same masks were exported as individual objects. Objects of a given size range were counted and calculated as percentage of total objects. Raw values from these masks were loaded into MiniTab 17 software. Two-sample *t* tests were carried out in MiniTab 17. All means shown are ± SE.

Reverse transcription PCR
-------------------------

Total RNA was extracted from HeLa cells using the RNeasy Plus kit (Qiagen, Valencia, CA). Custom cytohesin-2/ARNO primers were used to amplify 183-291 of cytohesin-2/ARNO (humanARNOfwd, 5-ACACGTGCTATGTGCTGTCC-3; humanARNOrev, 5-TAGTAGA­GGCAGTTGTCTGTGAGG-3); 53--169 of human GRP1 (humanGRP1fwd, 5-CGACAATCTAACTTCCGTAGAGG; humanGRP1rev, 5-TCAT­GCGATCAATCTTCTGC), and 46--147 of human R-Ras (RRasFwd, 5-CCATCCAGTTCATCCAGTCC-3; RRasRev, 5-CTCCAGATCTGCCTTGTTCC-3). ReadyMade primers to amplify glyceraldehyde-3-phosphate dehydrogenase (GAPDH) were obtained from Integrated DNA Technologies (Coralville, IA). Reverse transcription (RT)-PCR was performed with 100 ng of total RNA as template for GAPDH and 0.5 μg as template for ARNO and GRP1 using the Qiagen One-Step RT-PCR kit. RT-PCR reactions were treated with RNase cocktail (Ambion, Austin, TX) for 30 min at 37 degrees before gel electrophoresis. Band intensities were measured in ImageJ software (National Institutes of Health, Bethesda, MD).

Serum stimulation
-----------------

HeLa cells were Neon transfected, as described. Cells were allowed to recover for 5 h in antibiotic-free medium with 10% serum. After 5 h, cells were washed with phosphate-buffered saline (PBS), and serum-free/antibiotic-free medium containing [l]{.smallcaps}-glutamine was added for overnight serum starvation. After 18 h, cells were treated with dimethyl sulfoxide (DMSO; 1:1000) and 20% fetal bovine serum (FBS) in warm DMEM for 5 or 15 min. Time 0 cells were only treated with DMSO (1:1000) in warm DMEM. SecinH3 (1:1000 or 15 μM) was added to warm DMEM containing 0 or 20% serum before stimulation. After stimulation, cells were washed with PBS and fixed with 4% paraformaldehyde. For staining, cells were blocked and permeabilized using 0.1% Triton X-100 and 5% normal goat serum for 30 min. TS2/16 anti--β1 integrin antibody (Santa Cruz Biotechnology) was diluted in 1% bovine serum albumin (BSA) and 0.1% Triton X-100 in PBS, and coverslips were allowed to incubate for 1 h. Cells were washed in PBS, and mouse Alexa 594 or Alexa 647 (Jackson ImmunoResearch Laboratories) antibody was diluted and incubated for 1 h. Cells were washed in PBS and distilled water and mounted using ProLong Gold Antifade reagent (Life Technologies).

Transfection of siRNA-treated cells
-----------------------------------

Cells treated with siRNA (as described earlier) were transfected for siRNA using the Neon Transfection System. After 24 h, cells were transfected with Lipofectamine 3000 (Invitrogen) according to the manufacturer\'s instructions and allowed to express overnight to achieve 48 h of knockdown. After 48 h, the cells were fixed and mounted as described.

Saponin permeabilization
------------------------

Cells were transfected as described and allowed to express with serum overnight. The next day, cells were washed twice with PBS, and permeabilization buffer (modified from [@B42] ; 80 mM 1,4-piperazinediethanesulfonic acid, pH 6.5, 5 mM ethylene glycol tetraacetic acid, 1 mM MgCl~2~, 0.02% saponin, and sterile water) was added for 1 min. Cells were washed quickly with PBS and fixed and mounted as described.

Cell spreading assay
--------------------

We transfected 1 × 10^6^ cells with universal control siRNA or siRNA targeting human ARNO, using Neon. Cells to be treated with vector constructs were added to 12-well plates (6 × 10^4^), and cells to be harvested for RNA were plated on 6-cm plates (3.5 × 10^5^). The next day, cells were transfected with Turquoise LifeAct, Venus 38V R-Ras, or mCherry-ARNO and re-treated with siRNA (control siRNA, hARNO siRNA, or hR-Ras siRNA) using Lipofectamine 3000 according to the manufacturer\'s recommended instructions. Cells on 6-cm plates were harvested for total RNA using the RNeasy Plus Kit (Qiagen). Cells on 12-well plates were nonenzymatically harvested using 4 mM EGTA and 1 mM EDTA for 30 min. Cells were plated at subconfluency (30--40%) onto fibronectin-coated coverslips and allowed to spread for 20 or 35 min in FlouroBrite media (Life Technologies) containing 0.2% BSA, 10% FBS, and 2 mM [l]{.smallcaps}-glutamine. Cells were fixed and mounted onto coverglasses using ProLong Gold Antifade reagent (Life Technologies).
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ARF

:   ADP-ribosylation factor

ARNO

:   ADP-ribosylation factor nucleotide site opener

EHD1

:   Eps-15 homology domain--containing protein 1

GEF

:   guanine nucleotide exchange factor

GRP1

:   general receptor for phosphoinositides-1

RLIP76

:   Ral-interacting protein of 76 kDa
